ProCE Banner Activity

Slides: Expert Insight Key Data From ASCO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Conference Coverage
Slideset

Download these slides from Kathleen Moore, MD, and Nicoleta Colombo, MD, PhD, with key data for gynecologic cancers presented at the 2023 ASCO Annual Meeting, including practice updated results for immunotherapy in cervical cancer, data for novel immunotherapy-based combination in ovarian, and key results from combination immunotherapy plus chemotherapy combination as frontline treatment for advanced endometrial cancer.

Released: June 13, 2023

Share

Faculty

Nicoletta Colombo

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Kathleen N Moore

Kathleen N Moore, MD, MS

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director, Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Provided by

Provided by Clinical Care Options LLC

ProCE Banner

Supporters

This educational activity is supported by educational grants from AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp, Novocure, Genmab and Seagen.

AstraZeneca

Genmab

GlaxoSmithKline

Merck Sharp & Dohme Corp.

Novocure

Seagen